Abstract
With the potential to minimize the risk of many chronic diseases and the apparent biochemical safety of ingesting doses of oral vitamin D several-fold higher than the current recommended intakes, recent research has focussed on supplementing individuals with intermittent, high-dose vitamin D. However, two recent randomized controlled trials (RCTs) both using annual high-dose vitamin D reported an increase, rather than a decrease, in the primary outcome of fractures. This review summarises the results from studies that have used intermittent, high doses of vitamin D, with particular attention to those finding evidence of adverse effects. Results from observational, population-based studies with evidence of a U- or J-shaped curve are also presented as these findings suggest an increased risk in those with the highest serum 25D levels. Speculative mechanisms are discussed and biochemical results from studies using high-dose vitamin D are also presented. Emerging evidence from both observational studies and RCTs suggests there should be a degree of caution about recommending high serum 25D concentrations for the entire population. Furthermore, benefit of the higher doses commonly used in clinical practice on falls risk reduction needs to be demonstrated. The safety of loading doses of vitamin D should be demonstrated before these regimens become recommended as routine clinical practice. The current dilemma of defining vitamin D insufficiency and identifying safe and efficacious repletion regimens needs to be resolved.
Similar content being viewed by others
References
Mithal A, Wahl D, Bonjour J, Burckhardt P, Dawson-Hughes B, Eisman J et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820
Nowson C, McGrath J, Ebeling P, Haikerwal A, Daly R, Sanders K et al (2012) Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 196(11):686–687
Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151–1154
Henry HL, Bouillon R, Norman AW, Gallagher JC, Lips P, Heaney RP et al (2010) 14th Vitamin D Workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 121(1–2):4–6
Heaney RP, Holick MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26(3):455–457
Ebeling PR (2005) Megadose therapy for vitamin D deficiency. Med J Aust 183(1):4–5
Tang B, Eslick G, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588):657–1656
Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M et al (2010) Heterogeneity in serum 25-hydroxyvitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc 58:1489–1495
Leidig-Bruckner G, Roth H, Bruckner T, Lorenz A, Raue F, Frank-Raue K (2011) Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels—an observational study during clinical practice conditions. Osteoporos Int 22:231–240
Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J et al (2009) Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 183:1–420
Hansen KE (2011) High-dose vitamin D: helpful or harmful? Curr Rheumatol Rep 13(3):257–264
Holick M (2007) Medical progress: vitamin D deficiency. N Engl J Med 357:266–281
Committee to Review Dietary Reference Intakes for Calcium and Vitamin D, Food and Nutrition Board (2010) Dietary reference intakes for calcium and vitamin D. Institute of Medicine, Washington, DC
Lips P, Bouillon R, van Schoor NM, Vanderschueren D, Verschueren S, Kuchuk N et al (2010) Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf) 73(3):277–285
Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16(7):713–716
Heaney R (2008) Vitamin D: criteria for safety and efficacy. Nutr Rev 66(Suppl 2):s178–s181
Vieth R, Chan P, MacFarlane G (2001) Efficacy and safety of vitamin D3 input exceeding the lowest observed adverse effect concentration. Am J Clin Nutr 73:288–294
Montero-Odasso M, Duque G (2005) Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 26:203–219
Anderson P, May B, Morris H (2003) Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev 24:13–26
Group DIPART (2010) Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463
Elders P, Lips P, Netelenbos J, Van Grinkel F, Khoe E, Van der Vijgh W et al (1994) Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 9:963–970
Reid I, Mason B, Horne A, Ames R, Reid H, Bava U et al (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119(9):777–785
Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerio R, Carnevale V et al (2010) Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young people with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 95:4771–4777
Bacon C, Gamble G, Horne A, Scott M, Reid I (2009) High-dose vitamin D3 supplementation in the elderly. Osteoporos Int 20(8):1407–1415
Diamond T, Ho K, Rohl P, Meerkin M (2005) Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 183(1):10–12
Vieth R (2011) The pharmacology of vitamin D. In: Feldman D, Pike J, Adams J (eds) vitamin D. Academic Press, London, pp 1041–1066
Sanders K, Stuart A, Williamson E, Simpson J, Kotowicz M, Young D et al (2010) Annual high-dose oral vitamin D for falls and fractures in elderly women: a randomised, double-blind, placebo-controlled study. JAMA 303(18):1815–1822
Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C (2007) Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology 46(12):1852–1857
Bischoff-Ferrari H, Willett W, Wong J, Giovannucci E, Dietrich T, Dawson-Hughes B (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18):2257–2264
Bischoff-Ferrari H, Willett W, Wong J, Stuck A, Staehelin H, Orav J et al (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169(6):551–561
Reid I, Bolland M, Grey A (2008) Effect of calcium supplementation on hip fractures. Osteoporos Int 19(8):1119–1123
Cranney A, Weiler H, O’Donnell S, Puil L (2008) Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88(2):513S–519S
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58
Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almas B, Jorde R (2012) The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial. Osteoporos Int 23(1):201–211
von Restorff C, Bischoff-Ferrari H, Theiler R (2009) High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 45:747–749
Byrne P, Freaney R, McKenna M (1995) Vitamin D supplementation in the elderly: review of safety and effectiveness of different regimes. Calcif Tissue Int 56:518–520
Heaney R, Davies K, Chen T, Holick M, Barger-Lux M (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204–210
Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krueger D et al (2011) Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 96(4):981–988
Garland C, Garland F, Gorham E, Lipkin M, Newmark H, Mohr S et al (2006) The role of vitamin D in cancer prevention. Am J Public Health 96(2):252–261
Lin R, White J (2004) The pleiotropic actions of vitamin D. BioEssays 26(1):21–28
Evatt M (2010) Beyond vitamin status: is there a role for vitamin D in Parkinson disease? Arch Neurol 67(7):795–796
Grant W (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94(6):1867–1875
Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 70(21):8587–8597
Vieth R (2004) Enzyme kinetics hypothesis to explain the U-shaped risk curve for prostate cancer vs. 25-hydroxyvitamin D in Nordic countries. Int J Cancer 111(3):468
Grant WB (2004) Geographic variation of prostate cancer mortality rates in the United States: implications for prostate cancer risk related to vitamin D. Int J Cancer 111(3):470–472
Trivedi D, Doll R, Khaw K (2003) Effect of four monthly oral vitamin D supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326(7387):469–475
Ilahi M, Armas L, Heaney R (2008) Pharmokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 87:688–691
Rossini M, Adami S, Viapiana O, Fracassi E, Idolazzi L, Povino M et al (2012) Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers. Calcif Tissue Int 91:365–369
Sanders K, Ebeling P, Stuart A, Williamson E, Kotowicz M, Nicholson G (2011) Annual high-dose oral vitamin D3: is increased risk of fractures attributable to changes in bone turnover markers? In: ANZBMS/IOF JSBR annual scientific meeting, Gold Coast, Australia
Heikinheimo R (1992) Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51(2):105–110
Pasco J, Henry M, Kotowicz M, Sanders K, Seeman E, Pasco J et al (2004) Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 19(5):752–758
Dawson-Hughes B, Harris S (2010) High-dose vitamin D supplementation: too much of a good thing? JAMA 303(18):1861–1862
Ensrud K, Ewing S, Fredman L, Hochberg M, Cauley J, Hillier T et al (2010) Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab 95:5266–5273
Michaelsson K, Baron J, Snellman G, Gedeborg R, Bysberg L, Sundstrom J et al (2010) Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 92(4):841–848
McGrath J, Eyles D, Pedersen C, Ko P, Burne T et al (2010) Neonatal vitamin D status and risk of schizophrenia. Arch Gen Psychiatry 67(9):889–894
Lyons R, Johansen A, Brophy S, Newcombe R, Phillips C, Lervy B et al (2007) Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int 18(6):811–818
Sanders K, Stuart A, Williamson E, Jacka F, Dodd S, Nicholson G et al (2011) A randomised controlled trial investigating an annual high dose vitamin D3 and mental well-being: vital D study. Br J Psychiatry 198:357–364
Beckman MJ, Johnson JA, Goff JP, Reinhardt TA, Beitz DC, Horst RL (1995) The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D3 blunts parathyroid hormone induction of kidney 1-hydroxylase. Arch Biochem Biophys 319(2):535–539
Vieth R (2009) Proposal A: optimal health requires high 25OHD levels >40 ng/ml (>100 nmol/L). Fourteenth Workshop on Vitamin D. Brugge, Belgium, p 72
Sanders K, Ebeling P, Stuart A, Williamson E, Simpson J, Kotowicz M, et al. (2011) The efficacy of high-dose vitamin D3 administered once a year: is the increased risk of falls attributable to changes in muscle strength? American Society of Bone and Mineral Research scientific meeting. San Diego, CA, September 16–20
Reid IR (2010) Vitamin D—let’s get back to the evidence base. IBMS Bonekey 7(7):249–253
Buell JS, Dawson-Hughes B (2008) Vitamin D and neurocognitive dysfunction: preventing “D”ecline? Mol Aspects Med 29(6):415–422
Glendenning P, Zhu K, Inderjeeth C, Howat P, Lewis JR, Prince RL (2012) Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial. J Bone Miner Res 27(1):170–176
Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22(3):859–871
Cummings S (2010) A single, annual, high dose of oral vitamin D increased falls and fractures in older women. ACP J Club 153(3):JC3–3
Byers T (2010) Anticancer vitamins du jour—the ABCED’s so far. Am J Epidemiol 172(1):1–3
World Cancer Research Fund, American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
Francis R (2007) The vitamin D paradox. Rheumatology 46:1749–1750
Bouillon R, Norman AW, Lips P (2007) Vitamin D deficiency. N Engl J Med 357(19):1980–1981
Premaor MO, Scalco R, da Silva MJ, Froehlich PE, Furlanetto TW (2008) The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab 26(6):603–608
Pekkarinen T, Valimaki VV, Aarum S, Turpeinen U, Hamalainen E, Loyttyniemi E et al (2010) The same annual dose of 292000 IU of vitamin D (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D concentrations and renal function. Clin Endocrinol (Oxf) 72(4):455–461
Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K (2008) Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 264:599–609
Vieth R, Kimball S, Hu A, Walfish P (2004) Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 3:8
Law M, Withers H, Morris J, Anderson F (2006) Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 35:482–486
Aloia J, Bojadzievski T, Yusupov E, Shadzad G, Pollack S, Mikhail M et al (2010) The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial desigin. J Clin Endocrinol Metab 95(7):3216–3224
Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, Taylor PR et al (2007) Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97(1):123–128
Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N et al (2008) Serum vitamin D concentration and prostate cancer risk: a nested case–control study. J Natl Cancer Inst 100(11):796–804
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 108(1):104–108
Stolzenberg-Solomon R, Vieth R, Azad A, Pietinen P, Taylor P, Virtamo J et al (2006) A prospective nested case–control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66(20):10213–10219
Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT (2009) Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69(4):1439–1447
Flicker L, Mead K, MacInnis R, Nowson C, Scherer S, Stein M et al (2003) Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 51(11):1533–1538
Stein MS, Scherer SC, Ladd KS, Harrison LC (2011) A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer’s disease. J Alzheimers Dis 26(3):477–484
Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, Stahelin HB, Willett WC et al (2010) Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 170(9):813–820
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sanders, K.M., Nicholson, G.C. & Ebeling, P.R. Is High Dose Vitamin D Harmful?. Calcif Tissue Int 92, 191–206 (2013). https://doi.org/10.1007/s00223-012-9679-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-012-9679-1